These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 2596452)

  • 41. [Campylobacter pylori in endoscopic biopsies of the gastric antrum and its association with chronic gastritis].
    Ocaña Andrade E; Espinosa Soberanes JA; Marañón Sepúlveda M; Díaz Oyola M; Yañez Montes C
    Rev Gastroenterol Mex; 1989; 54(4):207-11. PubMed ID: 2616983
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Adenosine deaminase activity in the gastric mucosa of duodenal ulcer patients in relation to the severity of chronic gastritis and gastric acid secretion.
    Namiot Z; Namiot A; Kemona A; Stasiewicz J; Górski J
    Rocz Akad Med Bialymst; 2001; 46():309-16. PubMed ID: 11780574
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Long-term follow-up of Helicobacter pylori treatment in non-ulcer dyspepsia patients.
    Elta GH; Scheiman JM; Barnett JL; Nostrant TT; Behler EM; Crause I; Appelman HD
    Am J Gastroenterol; 1995 Jul; 90(7):1089-93. PubMed ID: 7611203
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [What is safe in the treatment of Campylobacter pylori-induced gastritis and Campylobacter pylori-associated peptic ulcer?].
    Menge H
    Internist (Berl); 1988 Nov; 29(11):745-54. PubMed ID: 3069787
    [No Abstract]   [Full Text] [Related]  

  • 45. Helicobacter pylori infection after gastrectomy and vagotomy in duodenal ulcer patients.
    Sito E; Konturek PC; Konturek SJ; Bielański W; Stachura J
    J Physiol Pharmacol; 1996 Mar; 47(1):229-37. PubMed ID: 8777304
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Pathogenicity of Campylobacter pylori--a causative factor in gastritis?
    McNulty CA
    Scand J Gastroenterol Suppl; 1989; 160():3-6. PubMed ID: 2683021
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Bismuth subsalicylate in the treatment of gastritis due to Campylobacter pylori.
    McNulty CA
    Rev Infect Dis; 1990; 12 Suppl 1():S94-8. PubMed ID: 2406863
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Nodular gastritis and Helicobacter pylori.
    Bujanover Y; Konikoff F; Baratz M
    J Pediatr Gastroenterol Nutr; 1990 Jul; 11(1):41-4. PubMed ID: 2388131
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Acid secretion and serum gastrin levels in individuals with Campylobacter pylori.
    Brady CE; Hadfield TL; Hyatt JR; Utts SJ
    Gastroenterology; 1988 Apr; 94(4):923-7. PubMed ID: 3345893
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Ulcer symptoms without demonstration of ulcer: causative therapy with demonstration of Helicobacter pylori].
    Kobler E; Müller B; Wüst W
    Schweiz Rundsch Med Prax; 1990 Mar; 79(13):398-9. PubMed ID: 2320815
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Campylobacter pyloridis-associated chronic active antral gastritis. A prospective study of its prevalence and the effects of antibacterial and antiulcer treatment.
    Rauws EA; Langenberg W; Houthoff HJ; Zanen HC; Tytgat GN
    Gastroenterology; 1988 Jan; 94(1):33-40. PubMed ID: 3335295
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Chronic active surface-positive Campylobacter antrum gastritis-- morphological changes 1 year after treatment with bismuth].
    Sorf M; Krislo V; Gogora M
    Vnitr Lek; 1991; 37(9-10):768-71. PubMed ID: 1771809
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Chronic alcoholic gastritis. Roles of alcohol and Helicobacter pylori.
    Uppal R; Lateef SK; Korsten MA; Paronetto F; Lieber CS
    Arch Intern Med; 1991 Apr; 151(4):760-4. PubMed ID: 2012461
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Bismuth subsalicylate suppression of Helicobacter pylori in nonulcer dyspepsia: a double-blind placebo-controlled trial.
    Marshall BJ; Valenzuela JE; McCallum RW; Dooley CP; Guerrant RL; Cohen H; Frierson HF; Field LG; Jerdack GR; Mitra S
    Dig Dis Sci; 1993 Sep; 38(9):1674-80. PubMed ID: 8359080
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Campylobacter pylori: a new pathogen.
    Czinn SJ; Speck WT
    Adv Pediatr Infect Dis; 1990; 5():221-37. PubMed ID: 2183821
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Effect of oral bismuth subsalicylate on Campylobacter pylori and on healing and relapse rate of peptic ulcer.
    Eberhardt R; Kasper G
    Rev Infect Dis; 1990; 12 Suppl 1():S115-9. PubMed ID: 2406852
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Campylobacter pylori gastritis: long term results of treatment with amoxycillin.
    Oderda G; Dell'Olio D; Morra I; Ansaldi N
    Arch Dis Child; 1989 Mar; 64(3):326-9. PubMed ID: 2495776
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Effects of antibacterial treatment of Campylobacter pylori-associated gastritis in children.
    De Giacomo C; Maggiore G; Licardi G; Scotta MS; Fiocca R
    Gastroenterology; 1988 Dec; 95(6):1699. PubMed ID: 3181694
    [No Abstract]   [Full Text] [Related]  

  • 59. Cytologic diagnosis of Campylobacter pylori-associated gastritis.
    Davenport RD
    Acta Cytol; 1990; 34(2):211-3. PubMed ID: 2321452
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Treatment of Campylobacter gastritis in young children.
    Bonamico M; Medici A; Chiesa C; Carpino F
    J Pediatr; 1989 Nov; 115(5 Pt 1):833-4. PubMed ID: 2624643
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.